1. Home
  2. BEEP vs TTRX Comparison

BEEP vs TTRX Comparison

Compare BEEP & TTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mobile Infrastructure Corporation

BEEP

Mobile Infrastructure Corporation

N/A

Current Price

$2.61

Market Cap

111.2M

Sector

Finance

ML Signal

N/A

TTRX

Turn Therapeutics Inc.

N/A

Current Price

$3.33

Market Cap

116.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BEEP
TTRX
Founded
2015
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Blank Checks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
111.2M
116.0M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
BEEP
TTRX
Price
$2.61
$3.33
Analyst Decision
Buy
Strong Buy
Analyst Count
1
1
Target Price
$6.50
$8.00
AVG Volume (30 Days)
35.2K
13.3K
Earning Date
06-03-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$35,075,000.00
N/A
Revenue This Year
$4.62
N/A
Revenue Next Year
$21.28
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.50
$2.57
52 Week High
$4.67
$5.98

Technical Indicators

Market Signals
Indicator
BEEP
TTRX
Relative Strength Index (RSI) 32.83 41.05
Support Level $2.53 $2.64
Resistance Level $3.25 $4.01
Average True Range (ATR) 0.21 0.21
MACD -0.06 0.01
Stochastic Oscillator 2.56 16.05

Price Performance

Historical Comparison
BEEP
TTRX

About BEEP Mobile Infrastructure Corporation

Mobile Infrastructure Corp focuses on acquiring, owning, and leasing parking facilities and related infrastructure, including parking lots, parking garages and other parking structures throughout the United States. It operates in a single reportable segment: parking. The parking segment derives revenue from managed property revenue and rental income at parking facilities. The company provide access to property and space for the parker's vehicle and charges fees that vary based on the level of usage. The company derives all of its revenue domestically.

About TTRX Turn Therapeutics Inc.

Turn Therapeutics Inc is a clinical-stage biotechnology company focused on developing pharmaceutical and medical device products for dermatology, wound care, and infectious disease. The company's proprietary platform technology, called PermaFusion, enhances drug performance by improving the stability and bioavailability of active pharmaceutical ingredients, which allows for reduced doses and fewer side effects. Its primary development programs target skin conditions such as moderate to severe eczema and onychomycosis.

Share on Social Networks: